DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Impact of Maternal Vitamin A or Beta-Carotene Supplementation on Maternal and Infant Mortality in Bangladesh

Information source: Johns Hopkins Bloomberg School of Public Health
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Vitamin A Deficiency; Maternal Mortality; Infant Mortality

Intervention: Vitamin A or Beta-Carotene Supplements (Dietary Supplement)

Phase: Phase 3

Status: Completed

Sponsored by: Johns Hopkins Bloomberg School of Public Health

Official(s) and/or principal investigator(s):
Keith P West, Jr., Dr.P.H., Principal Investigator, Affiliation: Johns Hopkins Bloomberg School of Public Health
Parul Christian, Dr.P.H., Study Director, Affiliation: Johns Hopkins Bloomberg School of Public Health
Rolf DW Klemm, Dr.P.H., Study Director, Affiliation: Johns Hopkins Bloomberg School of Public Health
Mahbubur Rashid, MBBS, MSc, Study Director, Affiliation: JiVitA Bangladesh Project
Alain B Labrique, MSc, Study Director, Affiliation: Johns Hopkins Bloomberg School of Public Health
Alfred Sommer, M.D., Study Director, Affiliation: Johns Hopkins Bloomberg School of Public Health

Summary

The purpose of this trial is to determine whether providing women with a weekly oral supplement of vitamin A, either preformed or as beta-carotene, at a dosage equivalent to a recommended intake from early pregnancy through three months postpartum, can reduce the risk of maternal mortality, fetal loss, or infant mortality.

Clinical Details

Official title: Impact of Maternal Vitamin A or Beta-Carotene Supplementation on Maternal and Infant Mortality in Bangladesh

Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Prevention

Primary outcome: All-cause, Pregnancy-related Mortality

Secondary outcome:

All-cause 3-month Infant Mortality

Maternal Morbidity, Including Obstetric Complications

Gestational Age at Birth

Fetal Growth and Postnatal Infant Growth Through Three Months of Age

Infant Morbidity Through 3 Months of Age

Plasma Beta-carotene in the Third Trimester of Pregnancy(Nutritonal Status of the Mother)

Plasma Retinol at the Third Trimester of Pregnancy (Nutritional Status of the Mother)

Detailed description: Maternal mortality and vitamin A deficiency coexist in rural South Asia. In Nepal, weekly supplementation with vitamin A or beta-carotene during the child-bearing years reduced all-cause maternal mortality and, in night blind women, also infant mortality. The present trial is testing the efficacy of the same supplements from ~9 weeks' gestation to 12 weeks postpartum. The planned sample size is 68,000 pregnancies. It is being conducted in 19 rural unions, covering an area of ~750 sq km with a population of ~580,000 in Gaibandha and Southern Rangpur Districts in Northern Bangladesh. The study area was mapped as 596 "sectors" (unit of randomization), each comprising 200-275 households; ~135,000 houses were numerically addressed and, at the outset, 103,000 women were listed. Women are visited at home every 5 weeks by 596 trained female staff to detect pregnancy by a combination of menstrual history and urine testing. Newly married women are prospectively enlisted for pregnancy surveillance. Following informed consent urine-positive (pregnant) women detected during surveillance are enrolled to receive weekly a capsule containing 7000 retinol equivalents of preformed vitamin A, 42 mg of beta-carotene or placebo. Vital events are recorded weekly through 3 months postpartum. Trained interviewers conduct maternal nutritional and health and household socioeconomic assessments in the 1st trimester. At 3 months postpartum, interviewers assess both mother and infant for health and nutritional status, including apparent birth defects that are later physician-confirmed. An additional home health assessment occurs at 6 months post partum, and vital status is recorded for mother and infant at one year postpartum. A ~3% subsample of enrolled pregnant women participate in a substudy involving enhanced clinical, anthropometric, biochemical, body compositional, morbidity and interview-based assessment protocols in the 1st, 2nd and 3rd trimesters, and at 3 months post-partum. Reported maternal and infant deaths are verified and causes ascertained during "verbal autopsy" interviews with family members of the deceased.

Eligibility

Minimum age: 15 Years. Maximum age: 49 Years. Gender(s): Female.

Criteria:

Inclusion Criteria:

- Married women of reproductive age

- First pregnancy during time period of trial

Exclusion Criteria:

- Premenarchial girls

- Married women with a previous pregnancy enrolled into the trial

- Previously married women who have moved into the study area

- Single women (never married, widowers)

- Women who are sterilized (or whose husbands are sterilized)

- Menopausal women

Locations and Contacts

Johns Hopkins School of Public Health, Baltimore, Maryland 21205, United States

JiVitA Bangladesh Project, Rangpur, Rajshahi Division, Bangladesh

JiVitA Project Office, Rangpur, Rangpur District 5400, Bangladesh

Additional Information

Micronutrient research at the Center for Human Nutrition at Johns Hopkins Bloomberg School of Public Health

Related publications:

West KP Jr, Katz J, Khatry SK, LeClerq SC, Pradhan EK, Shrestha SR, Connor PB, Dali SM, Christian P, Pokhrel RP, Sommer A. Double blind, cluster randomised trial of low dose supplementation with vitamin A or beta carotene on mortality related to pregnancy in Nepal. The NNIPS-2 Study Group. BMJ. 1999 Feb 27;318(7183):570-5.

Katz J, West KP Jr, Khatry SK, Pradhan EK, LeClerq SC, Christian P, Wu LS, Adhikari RK, Shrestha SR, Sommer A. Maternal low-dose vitamin A or beta-carotene supplementation has no effect on fetal loss and early infant mortality: a randomized cluster trial in Nepal. Am J Clin Nutr. 2000 Jun;71(6):1570-6.

Christian P, West KP Jr, Khatry SK, LeClerq SC, Kimbrough-Pradhan E, Katz J, Shrestha SR. Maternal night blindness increases risk of mortality in the first 6 months of life among infants in Nepal. J Nutr. 2001 May;131(5):1510-2.

Christian P, West KP Jr, Khatry SK, Katz J, LeClerq SC, Kimbrough-Pradhan E, Dali SM, Shrestha SR. Vitamin A or beta-carotene supplementation reduces symptoms of illness in pregnant and lactating Nepali women. J Nutr. 2000 Nov;130(11):2675-82.

Christian P, West KP Jr, Khatry SK, Kimbrough-Pradhan E, LeClerq SC, Katz J, Shrestha SR, Dali SM, Sommer A. Night blindness during pregnancy and subsequent mortality among women in Nepal: effects of vitamin A and beta-carotene supplementation. Am J Epidemiol. 2000 Sep 15;152(6):542-7.

West KP Jr. Extent of vitamin A deficiency among preschool children and women of reproductive age. J Nutr. 2002 Sep;132(9 Suppl):2857S-2866S. Erratum in: J Nutr 2002 Nov;132(11):3432.

Starting date: August 2001
Last updated: March 5, 2012

Page last updated: August 20, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017